Advertisement
Screener

UroGen Pharma Ltd. (URGN) ROA

UroGen Pharma Ltd. (URGN) ROA

  • 2026-06-30: ROA -38.65%.
  • 2026-03-31: ROA -52.51%.
  • 2025-12-31: ROA -76.57%.
  • 2025-09-30: ROA -88.97%.

Complete source-backed roa history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-38.65%
2026-03-31-52.51%
2025-12-31-76.57%
2025-09-30-88.97%
2025-06-30-74.25%
2025-03-31-55.91%
2024-12-31-44.41%
2024-09-30-38.21%
2024-06-30-40.30%
2024-03-31-52.01%
2023-12-31-57.34%
2023-09-30-54.28%
2023-06-30-114.35%
2023-03-31-98.80%
2022-12-31-80.95%
2022-09-30-85.13%
2022-06-30-77.83%
2022-03-31-68.36%
2021-12-31-92.55%
2021-09-30-83.87%
2021-06-30-72.51%
2021-03-31-119.72%
2020-12-31-105.31%
2020-09-30-97.88%
2020-06-30-80.93%
2020-03-31-72.78%
2019-12-31-51.95%
2019-09-30-39.64%
2019-06-30-36.96%
2019-03-31-33.22%
2018-12-31-73.06%
2018-09-30-55.11%
2018-06-30-34.40%
2018-03-31-23.16%
2017-12-31-26.47%

Annual ROA

DateROA
2025-12-31-76.57%
2024-12-31-44.41%
2023-12-31-57.34%
2022-12-31-80.95%
2021-12-31-92.55%
2020-12-31-105.31%
2019-12-31-51.95%
2018-12-31-73.06%
2017-12-31-26.47%
2016-12-31-8.42%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Generate Biomedicines, Inc. (GENB)United States$2.052B
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B